The full set of IPDR.org technologies include the IPDR/Streaming Protocol (IPDR/SP) transport, the IPDR binary encoding, along with open source code of reference implementations and development tools for integration of the technology into vendor solutions.
IPDR.org's president and COO Kelly Anderson explained, "The integration of IPDR.org technologies into OCAP represents a significant impact to the cable industry and offers cable operators the capability of providing detailed metrics from the home network with next generation television, communication and entertainment," she said.
"CableLabs' has already adopted IPDR Streaming Protocol for DOCSIS and their experience has prepared them for today's next-generation of open STB requirements.
Frank Sandoval, director, OCAP Specifications in the CableLabs Advanced Platforms and Services Department, said the IPDR technology was a great fit for the OpenCable specifications.
IPDR Streaming Protocol is also well-adopted by the industry, as evident by its approval by the Alliance for Telecommunication Industry Solutions' (ATIS) as an American National Standard for Service-neutral Usage Data Management (ATIS-0300075.1.2006).
About IPDR.org IPDR.org is the only collaborative industry consortium exclusively focused on developing and driving the adoption of next-gen IP service usage exchange standards worldwide.
The IPDR is the latest in a series of program milestones that confirms FCS modernization meets the Army's cost projections, time schedule, and performance expectations.
"IPDR represents the transition from requirements to design, build, integrate, and test," said Maj.
During the IPDR, each system team provided a detailed technical work plan for the next two years.
The IPDR also demonstrated the maturity of the overall FCS baseline design concept.
"Our goals for the remainder of 2005 include presenting interim results on the first wave of Talotrexin clinical trials; initiating a phase I IPdR
clinical trial in colorectal, gastric, pancreatic and liver cancers; and commencing pivotal clinical trials in OLS (ondansetron lingual spray) for a 505(b)(2) NDA filing in 2006."